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Abstract
Aims: The aim of this study was to estimate the effects of lifestyle interventions on
bodyweight and other cardiometabolic risk factors in people with psychotic
disorders. Additionally, the long-term effects on body weight and the effects on
depressive symptoms were examined.
Material and Methods: We searched four databases for randomized controlled
trials (RCTs) that compared lifestyle interventions to control conditions in patients
with psychotic disorders. Lifestyle interventions were aimed at weight loss or weight
gain prevention, and the study outcomes included bodyweight or metabolic
parameters.
Results: The search resulted in 25 RCTs -only 4 were considered high quality-
showing an overall effect of lifestyle interventions on bodyweight (effect size
(ES)520.63, p,0.0001). Lifestyle interventions were effective in both weight loss
(ES520.52, p,0.0001) and weight-gain-prevention (ES520.84, p50.0002).
There were significant long-term effects, two to six months post-intervention, for
both weight-gain-prevention interventions (ES520.85, p50.0002) and weight loss
studies (ES520.46, p50.02). Up to ten studies reported on cardiometabolic risk
factors and showed that lifestyle interventions led to significant improvements in
waist circumference, triglycerides, fasting glucose and insulin. No significant effects
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were found for blood pressure and cholesterol levels. Four studies reported on
depressive symptoms and showed a significant effect (ES520.95, p50.05).
Conclusion: Lifestyle interventions are effective in treating and preventing obesity,
and in reducing cardiometabolic risk factors. However, the quality of the studies
leaves much to be desired.
Introduction
Psychosis is the psychiatric term for a state of mind in which a person suffers from
delusions (false beliefs that hinder a persons’ ability to function) or hallucinations
(false sensory perceptions) that are not accompanied by insight [1]. Psychotic
disorders include schizophrenia, schizophreniform disorder, schizoaffective
disorder and delusional disorder among others. The hallucinations and delusions
can be treated effectively with different types of antipsychotic drugs. However, the
use of antipsychotic drugs often coincides with metabolic side-effects, such as
dyslipidemia, hyperglycemia and an increase in body weight and waist
circumference [2–4]. Obesity is a serious problem in people with psychotic
disorders. The prevalence of obesity among people with psychotic disorders is 41–
50%, which is substantially higher than the 20–27% prevalence in the general
population [5]. A recent study mapped the body weight of people with
schizophrenia during three years of antipsychotic drug use. This study showed
that 34–55% of the patients with normal weight or underweight (Body Mass
Index [BMI]),25 kg/m2) at baseline gained $7% of their body weight. Among
the patients who were already overweight or obese (BMI$25 kg/m2) at baseline
this percentage was 12–42% [6]. Since obesity is a known risk factor for
cardiovascular disease, this phenomenon is of major importance for the
development of comorbidities in people with psychotic disorders. The
cardiovascular risk that is imposed by obesity is about four times higher in people
with psychotic disorders than in the general population [7]. Cardiovascular
disease is one of the major causes for premature mortality in these patients [7, 8].
Not only weight gain but also increased waist circumference, high blood pressure,
higher levels of triglycerides, high cholesterol and higher levels of fasting glucose
and insulin contribute to the risk of cardiovascular disease and premature
mortality [7, 9]. Clinical guidelines emphasize the importance of health
monitoring in these patients and recommend at least annual check-ups, but they
offer no recommendations with regard to lifestyle interventions [10]. Studies in
the general population as well as studies in people with psychiatric disorders
consistently suggest that healthy lifestyle interventions might decrease cardio-
vascular risk [11]. Interventions that include physical activity and improved
nutritional habits presumably lead to weight reduction and increased cardiovas-
cular fitness [12, 13]. Behavioral interventions aimed at weight loss seem
promising as well, with two studies suggesting that these interventions could
Lifestyle Interventions and Cardiometabolic Risk in Psychosis
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improve health outcomes associated with cardiometabolic risk [12, 14]. To date,
several studies have examined the effectiveness of different lifestyle interventions
in patients with psychotic disorders; numerous randomized controlled trials
(RCTs) as well as a number of meta-analyses [15–17] and systematic reviews have
been published [14, 18, 19]. The available reviews to date however show several
limitations. First, the only meta-analysis that reported long-term post-interven-
tion results [17] did not include all available studies [20–26]. Second, the quality
of RCTs included in the available meta-analyses has not been assessed. Including
low quality trials may yield biased results. Third, only two of the available meta-
analyses included the effects of lifestyle interventions on cardiometabolic risk
[16, 17]. The authors of these studies however did not report results on all relevant
metabolic outcomes that were available, even though these are important factors
with regard to comorbidities and mortality in this patient group. Fourth, two of
the reviews had a limited patient sample: one only included studies in patients
with diabetes [18] and one could not include any study because their inclusion
criteria stated patients should be in primary care [19]. Last, none of the available
meta-analyses reported on the effects of lifestyle interventions on depressive
symptoms, although it has been widely recognized that patients with psychotic
disorders often suffer from comorbid depressive symptoms [27–29], and that
increased physical activity in these patients has been associated with lower levels of
depression [30].
Aims of the study
This study aims to investigate the effect sizes (ES) of lifestyle interventions on
body weight and other cardiometabolic risk factors, such as waist circumference,
blood pressure, blood lipids, glucose and insulin concentrations, in patients with
psychotic disorders. The long-term effects of lifestyle interventions on body
weight are included in the analysis as well. In addition, the effects of lifestyle
interventions on depressive symptoms are investigated. Furthermore, we attempt
to find effective components of the interventions, by comparing the studies with
the largest ES and examine potential overlap and differences between the elements
used in these successful interventions.
Materials and Methods
Inclusion criteria
A systematic search for all randomized controlled trials evaluating the effects of
lifestyle interventions on weight management in patients with psychotic disorders
was conducted until April 2014. The following electronic databases were searched:
PubMed, Web of Science, PsycINFO and MEDLINE. Search terms included:
schizophrenia or schizophrenic or psychotic or schizoaffective disorder or mental
disorder or mentally ill or psychiatric disorders or severe mental illness or
antipsychotic AND lifestyle intervention or diet or physical activity or nutrition or
Lifestyle Interventions and Cardiometabolic Risk in Psychosis
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lifestyle or body weight or weight loss or weight management or exercise AND/OR
weight gain or metabolic or metabolic syndrome or diabetes or health or somatic
AND/OR psychological intervention or counseling or directive counseling or
cognitive behavioral treatment. We included all randomized controlled trials
(RCTs) that examined lifestyle interventions; i.e. interventions either targeting
overweight patients in order to help them lose weight, or patients in the early
stages of their illness in order to help them prevent antipsychotic induced weight
gain. Interventions were considered lifestyle interventions when they had a
nutritional element, physical activity and/or a psychological intervention aimed at
weight loss or weight gain prevention. In eligible studies, all included subjects
were diagnosed with psychotic disorders and study outcomes were either body
weight or cardiometabolic risk factors (e.g. waist circumference, blood pressure,
blood lipids, glucose and/or insulin). Pharmacological interventions were
excluded, as were non-randomized studies and studies that did not qualify as
lifestyle interventions. These selection criteria were first applied to the title. When
the title did not present exclusion criteria (e.g. non-RCT, no intervention, no
psychotic disorders) or was inconclusive, the abstracts of the articles were read
and -where necessary- the full articles. Finally, the bibliographies of selected
articles were searched for relevant references to be included in our analysis.
Outcomes and calculations
The first outcome was mean body weight change, measured directly at the end of
the intervention. An overall ES for lifestyle interventions was calculated as well as
separate ES for weight loss interventions and weight gain prevention interven-
tions. The same analyses were performed for the long-term effects. A sensitivity
analysis was performed using the ‘Clinical Trials Assessment Measure for
psychological treatments’ (CTAM) to assess the quality of the studies [31]. The
CTAM determines the quality of a study based on sample size and recruitment
method, allocation to treatment, assessment of outcome, control groups,
description of treatments and analysis. The psychometric properties of the CTAM
were found to be adequate [31]. Only the studies marked as high quality
(CTAM$65) were included in the sensitivity analysis. Next, we calculated the ES
of lifestyle interventions on cardiometabolic risk factors and depressive symptoms.
With regard to cardiometabolic risk, we examined all available metabolic
parameters, which include waist circumference, systolic and diastolic blood
pressure, total cholesterol, HDL-cholesterol, LDL-cholesterol, triglyceride con-
centrations, fasting glucose concentrations and fasting insulin concentrations. For
depression we considered the mean changes on the depression scales reported in
the studies.
Data extraction
Relevant data that were extracted include a) patient characteristics [gender, age,
diagnoses], b) intervention characteristics [duration, components, aim], c) study
Lifestyle Interventions and Cardiometabolic Risk in Psychosis
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characteristics [dropouts, number of participants, blind assessments, control
condition], d) means and standard deviations of baseline and endpoint or change
scores of the outcome body weight, e) means and standard deviations of body
weight at follow-up, f) means and standard deviations of baseline and endpoint or
change scores of the components of all cardiometabolic risk factors as described
above, g) means and standard deviations of baseline and endpoint or change
scores of the outcome depressive symptoms.
In a meta-analysis all data is pooled and some variation in the intervention
effects are to be expected. When the observed intervention effects are more
different from each other than would be expected from random error (chance)
alone it is called heterogeneity. Heterogeneity, characterized by the I2 statistic, is
considered low when I2#25% and high when I2$75% [32].
Meta-analytic procedure
To standardize the outcome among studies, Cohen’s d was used as a measure of
ES [33]. It was calculated using the following equation:
Effect size Cohen;sd½ ~ MI{MCð Þ=SDpooled
The MI indicates the mean pre-post intervention difference in the intervention
group, whereas Mc is the mean pre-post intervention difference in the control
group. SDpooled indicates the pooled standard deviation for both groups within
one report. The Standard Error of the ES (Cohen’s d) was calculated by using the
following equation [34]:
Standard Error Cohen;sd½ 
~sqrt niznc½ = ni|nc½ ð Þz d|2= 2| niznc{2ð Þ½ ð Þ
in which ni and nc indicate the number of participants in the intervention
group and the number of participants in the control group respectively, whereas d
stands for Cohen’s d. We calculated separate ES for the intervention and control
group in studies that did not report the mean weight change, but only the mean
weight at baseline and endpoint. Cohen’s d was then estimated by subtracting the
ES of the control group from the ES of the intervention group. Standard Error of
the ES was established by the formula mentioned above. Missing data with regard
to standard deviations were imputed from the included studies. This meta-
analysis was performed and written in accordance with the PRISMA-guidelines
[35].
Lifestyle Interventions and Cardiometabolic Risk in Psychosis
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Statistical method
The data were analyzed in RevMan Version 5.0 (Cochrane Collaboration software
for meta-analyses) with the Inverse Variance method, using random effects
models [36]. The x2 test, based on the Q-statistic, was performed to check for the
homogeneity of the effects with I2 as a quantifiable measure of heterogeneity [32].
Funnel plots were checked for asymmetry and Eggers’ tests were performed for




The search resulted in 656 records in four databases. A screening of the articles
and their references initially resulted in 32 eligible studies that were discussed
within the research group (JB, FJ, EC, MP), which led to the exclusion of seven
more studies: in five of these studies the participants were not randomly assigned
to the experimental or the control group [38–42], and the two other studies did
not meet the criteria of a lifestyle intervention [43, 44]. The remaining 25 RCT’s
were included in the meta-analysis (see Figure 1). Twenty-four RCT’s reported on
body weight (sixteen on weight loss and eight on weight gain prevention), seven
RCT’s had long-term follow-up data on body weight (four on weight loss and
three on weight gain prevention), fifteen RCT’s reported on one or more
cardiometabolic risk factors and four RCT’s reported depression. Six of the
studies had missing standard deviations [45–50], which were imputed from the
data pool. All articles were published in English up to the last date of the search
(April 2014).
Study characteristics
A total of 1518 participants were included in the meta-analysis. Sample sizes
across the studies varied from 14 to 291 participants with 52% male patients. The
mean age across the studies varied from 26.1 (SD510.2) to 54.0 (SD59.3). Fifteen
of the studies reported the use of mental health professionals, dieticians and/or
exercise specialists to implement the intervention. Interventions were performed
in the United States of America [22, 25, 50–55], South-America [21], Canada [48],
the United Kingdom [45, 46], Spain [56, 57], Italy [47, 49, 58], Sweden [59],
Switzerland [24], the Netherlands [60], Australia [23], Korea [61], Thailand [62],
Taiwan [63] and China [64]. An overview of the study characteristics is provided
in Table 1. The classification of weight loss study or weight prevention study was
solely based on the aim of the researchers of the study. There were no differences
with regard to the content of lifestyle interventions.
Lifestyle Interventions and Cardiometabolic Risk in Psychosis
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Figure 1. Prisma 2009 Flow Diagram.
doi:10.1371/journal.pone.0112276.g001
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setting Diagnoses Intervention Control condition
Poulin et al.
(2007)
59 (a) 51 (b) 8% Outpatients Schizophrenia, schizoaf-
fective disorder, bipolar
disorder










12 week intervention, weekly 30 minute
session.

















3 month intervention with 6 individual
sessions of one hour.
Counseling and tailored advise.
Olanzapine and passive
nutrition information




32 (a) 32 (b) 8% First psychosis First psychotic episode of
schizophrenia







28 (a) 29 (b) 19% Outpatients Schizophrenia, schizoaf-
fective disorder and dia-
betes
mellitus
24 week intervention with weekly group
sessions.
Diet encouragement and non-structured
exercise.






8 (a) 10 (b) 22% Outpatients Schizophrenia, schizoaf-
fective disorder







33 (a) 15 (b) 25% Outpatients Schizophrenia, schizoaf-
fective disorder
12 week intervention with 8 individual
sessions.
Nutrition and activity assessment, non-
structured
exercise and tailored advise.







35 (a) 35 (b) n.m. Outpatients Schizophrenia, schizoaf-
fective disorder























5 session intervention. Nutrition and
activity assessment,






8 (a) 7 (b) 12% Outpatients Schizophrenia, schizoaf-
fective disorder
16 week intervention with weekly group
sessions.







32 (a) 32 (b) 0% Inpatients Schizophrenia 3 month intervention with group educa-
tions,
5 hourly individual sessions and practicing
pedometer
walking. Non-structured exercise, motiva-
tional interviewing
and counseling.
Receiving a folder about
healthy lifestyle
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15 (a) 13 (b) 39% n.m. Severe and enduring
mental illness

















18 months with group and individual
weight management







81 (a) 79 (b) 21% Outpatients Schizophrenia, other psy-
chotic disorder
12 weekly group sessions including
patients and family members,
discussing diet, physical activity and
stress.




34 (a) 37 (b) 31% Outpatients Schizophrenia, schizoaf-
fective disorder
14 week interventions with 20 group
sessions.






9 (a) 11 (b) 33% Inpatient and out-
patient
DSM IV mood- or psy-
chotic disorder
12 week intervention with 4 hourly group
sessions per week







22 (a) 14 (b) n.m. n.m. Schizophrenia, bipolar
with a manic episode
12 week intervention with 3 sessions per
week of 30–60 minutes.





31 (a) 30 (b) 13% n.m. Receiving antipsychotic
treatment
12 week intervention with weekly group
sessions.
Diet encouragement, nutrition assess-
ment, non-structured exercise,
motivational interviewing and CBT.







47 (a) 42 (b) 35% n.m. Serious mental illness 12 month intervention with 3 month
intensive, 3 month maintenance and 6
month
intermittent support phase.









12 month intervention, once a week
cooking
















10 (a) 10 (b) 10% n.m. Schizophrenia, schizoaf-
fective disorder
8 week intervention with weekly individual
visits to a psychiatrist
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Overall results for interventions on body weight
The overall ES of lifestyle interventions on weight was 20.63 (95% CI520.84 to
20.42). Lifestyle interventions had a significant, beneficial effect on weight loss
(p,0.00001) (see Figure 2a). The experimental groups in the weight loss
intervention studies showed a higher reduction of the mean body weight than the
control groups (ES520.52 with the 95% CI520.72 to 20.31, p,0.00001) (see
Figure S1a). In the weight gain prevention studies the experimental groups gained
less body weight than the control groups (ES520.84 with the 95% CI521.28 to
20.40, p50.0002) (see Figure S1b). The included studies in this meta-analysis
showed moderate heterogeneity. The overall intervention effect had an I2 of 70%.
Among the weight loss intervention studies I2 was 55% while the I2 was 76% in
the weight gain prevention studies.
Study quality assessment
First, the funnel plots did not show asymmetry, but the Egger’s tests showed that
publication bias could not be ruled out for diastolic blood pressure (p50.078)
and long-term body weight (p50.027). All other outcomes had p-values above the
recommended 0.1 on the Egger’s test, varying from 0.185 to 0.961 (see Table S1)
[37]. All studies report randomization, but only 10 studies describe the
randomization process [21, 22, 45, 46, 52, 56, 57, 59, 62, 64]. Five studies report the
use of assessors independent from the study [55–57, 63, 64]; assessors were
reported to be blind to group allocation in nine studies [21, 45, 46, 48, 52, 55–
57, 64]. One study failed to adequately describe the treatment [57]. The mean
drop-out rate among the studies was 17%, varying from 0–39%, but only four
studies described an acceptable strategy for investigating drop-outs
[51, 52, 56, 64]. Intention-to-treat analyses were reported in twelve studies
[21, 45, 46, 51, 52, 56, 58–62, 64]. Four of the studies were considered to be of
sufficient quality and had a CTAM score of at least 65 [52, 56, 59, 64]. Sensitivity
















6 month intervention, two hours a week
exercise under supervision,





(a) Number of patients in the intervention group. (b) Number of patients in the control group. N.m.5not mentioned. Structured diet: prescribed diet, specific
instructions regarding food- and/or calorie-intake. Non-structured diet encouragement: informing patients about healthy food, provide healthy food
suggestions, cooking healthy meals, reimbursing purchase of healthy food and encourage healthy eating behavior without structured restrictions. Nutrition
assessment: food diary or discussing food intake with nutritionist. Supervised exercise: exercising under supervision of a (personal) trainer. Non-
structured exercise: unsupervised exercise, providing opportunity to exercise (e.g. free gym-membership), encouragement to enhance frequency and
intensity of physical activity. Activity assessment: activity diary, discussing physical activities during sessions. Psychological interventions: motivational
interviewing, counseling and goal-setting, cognitive-behavioral therapy (CBT) and individually tailored advice.
doi:10.1371/journal.pone.0112276.t001
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significant ES of 20.55 (95% CI520.96 to 20.14, p50.008) of lifestyle
interventions on body weight (see figure S2a).
Long term effects
Seven studies reported follow up data between two and six months after the
completion of the intervention [20–26]. Their combined ES was 20.62 (95% CI:
Figure 2. Forest plot a) describes the effects of lifestyle interventions on bodyweight. Forest plot b) describes the longterm effects of lifestyle
interventions on body weight. Forest plot c) describes the effects of lifestyle interventions on depressive symptoms.
doi:10.1371/journal.pone.0112276.g002
Lifestyle Interventions and Cardiometabolic Risk in Psychosis
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20.93 to 20.31, p,0.0001) as is described in Figure 2b, which is in favor of the
intervention. When we analyzed weight loss and weight gain prevention studies
separately, we found that interventions aimed at weight gain prevention have a
large long-term effect (ES520.85, 95% CI521.29 to 20.41, p50.0002) (see
figure S3b) while the long-term effect of the weight loss interventions was
moderate (ES520.46, 95% CI520.83 to 20.08, p50.02) (see figure S3a). With
regard to heterogeneity, I2 was 63% for the overall long-term effects of the
intervention, 51% in the weight gain prevention studies and 62% in the weight
loss studies.
Cardiometabolic risk
Ten studies reported cardiometabolic risk factors and in these studies there were
no distinct differences between the weight loss interventions and the weight gain
prevention interventions with respect to the content of the intervention.
Therefore, in the analyses of the metabolic parameters, the two types were taken
together. The lifestyle interventions demonstrated significant effects for waist
circumference, triglycerides, fasting glucose and insulin. The ES for cholesterol
(total, HDL-C and LDL-C) and systolic and diastolic blood pressure were not
significant. An overview is provided in Table 2. Three of the high quality studies
Table 2. Effects of lifestyle interventions on cardiometabolic risk.
Parameters N studies N[i]* N[c]+ Cohens d 95% CI p I2
Waist circumference (cm)# 10 385 320 20.37 [20.60; 20.13] 0.002 56%
Systolic blood pressure (mmHg)$ 7 308 307 20.22 [20.49; 0.05] 0.10 60%
Diastolic blood pressuye (mmHg)£ 3 95 76 20.08 [20.57; 0.41] 0.74 64%
Triglycerides (mg/dl)d 8 338 321 20.27 [20.49; 20.04] 0.02 51%
HDL-cholesterol (mg/dl)D 8 319 308 0.28 [20.16; 0.73] 0.21 91%
LDL-cholesterol (mg/dl)h 5 258 259 20.27 [20.75; 0.22] 0.28 87%
Total cholesterol (mg/dl)1 7 295 295 20.27 [20.59; 0.05] 0.10 72%
Fasting glucose (mg/dl) 8 347 341 20.24 [20.32; 20.10] 0.001 0%
Insulin (mIU/ml)y 6 241 240 20.28 [20.56; 20.01] 0.04 52%
*Total N in intervention groups.
+Total N in control groups.
#Attux et al. (2013), Daumit et al. (2013), Evans et al. (2005), Forsberg et al. (2008), Iglesias-Garcia et al. (2010), McKibbin et al. (2006), Methapatara et al.
(2011), Poulin et al. (2007), Scheewe et al. (2013) & Wu RR et al. (2008).
$Attux et al. (2013), Brar et al. (2005), Brown & Smith et al. (2009), Daumit et al. (2013), Forsberg et al. (2008), McKibbin et al. (2006) & Scheewe et al.
(2013).
£Forsberg et al. (2008), McKibbin et al. (2006) & Scheewe et al. (2013).
dAttux et al. (2013), Daumit et al. (2013), Forsberg et al. (2008), Mauri et al. (2008), McKibbin et al. (2006), Poulin et al. (2007), Scheewe et al. (2013 &, Wu
MK et al. (2007).
DAttux et al. (2013), Daumit et al. (2013), Forsberg et al. (2008), Mauri et al. (2008), McKibbin et al. (2006), Poulin et al. (2007), Scheewe et al. (2013) &
Skrinar et al. (2005).
hAttux et al. (2013), Daumit et al. (2013), Mauri et al. (2008), McKibbin et al. (2006) & Poulin et al. (2007).
1Attux et al. (2013), Daumit et al. (2013), Forsberg et al. (2008), Mauri et al. (2008), McKibbin et al. (2006), Poulin et al. (2007) & Wu MK et al. (2007).
"Attux et al. (2013), Daumit et al. (2013), Mauri et al. (2008), McKibbin et al. (2006), Poulin et al. (2007), Scheewe et al. (2013), Wu MK et al. (2007) & Wu
RR et al. (2008).
yAttux et al. (2013), Daumit et al. (2013), Forsberg et al. (2008), Mauri et al. (2008), Wu MK et al. (2007) & Wu RR et al. (2008).
doi:10.1371/journal.pone.0112276.t002
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also reported on waist circumference and insulin [52, 59, 64]. A sensitivity analysis
that only included the three high quality studies resulted in slightly decreased
effect sizes that were no longer statistically significant for both waist circumference
(ES520.30, 95% CI520.63 to 0.03, p50.08) (see figure S2b) and insulin
(ES520.26, 95% CI520.64 to 0.12, p50.18) (see figure S2c). Regarding
heterogeneity, only in the studies with fasting glucose I2 was 0%. The remaining
components had moderate to high heterogeneity with I2 varying from 51% to
91% (see Table 2).
Depressive symptoms
Four studies reported the effects of lifestyle interventions on depressive symptoms
based on a continuous depression scale. Skrinar et al. (2005) used the depression
scale of the SCL-90-R, Scheewe et al. (2013) used the Montgomery A˚sberg
Depression Rating Scale (MADRS) and the remaining studies reported the
depression score of the Hospital Anxiety and Depression Scale (HADS) [45, 46].
The overall ES for lifestyle interventions on depressive symptoms was20.95 (95%
CI521.90 to 20.00, p50.05). An overview of the results is shown in Figure 2c.
None of the studies reporting depression had a CTAM score of 65 or above, so
these results should interpreted with caution. Heterogeneity among the studies
with outcome depression was high (I2593%).
Intervention characteristics
Most of the studies had an intervention period of three months or less
[21, 23, 24, 45–47, 49, 50, 56–58, 61, 62, 64]. Seven studies had an intervention
period between three and six months [25, 51, 53–55, 60, 63] and four studies had
an intervention period of twelve months or more [22, 48, 52, 59]. There were also
differences between the intensity and duration of the supervised exercise sessions.
Exercise sessions varied from two hours per week [48, 59, 60] to 45 minutes
supervised exercise four times a week [50] or daily 30 minutes sessions [22]. We
studied the interventions with large effect sizes for corresponding intervention
elements. However, we did not find any element present in all or most of the
interventions with the largest effect sizes, nor did we find corresponding elements
for the interventions with the smallest effect sizes. We did find a difference in the
ES of interventions depending on whether group- or individually based
interventions were used. Five studies used an individual approach in their
intervention [23, 45, 49, 56, 61]. Their combined ES was 20.67 (p50.0004) (see
figure S4a). Ten studies presented their patients with a group intervention
[21, 22, 24, 25, 50, 51, 55, 57, 59, 63].The group interventions had an overall ES of
20.36 (p50.002) (see figure S4b). A combined approach of a group interventions
accompanied by individual sessions was used in five studies [48, 52, 53, 62, 64].
They showed the largest overall ES (ES520.99, p50.002) (see figure S4c).
Lifestyle Interventions and Cardiometabolic Risk in Psychosis
PLOS ONE | DOI:10.1371/journal.pone.0112276 December 4, 2014 13 / 20
Discussion
Lifestyle interventions led to weight reduction and weight gain prevention.
Significant positive effects on body weight remained at follow-up. Effect sizes for
weight gain prevention interventions were large and the effects of the weight loss
interventions moderate. Results showed that lifestyle interventions also led to
reductions in waist circumference, triglycerides, fasting glucose and insulin. No
significant effects were found for blood pressure and cholesterol levels. Only four
of 25 studies were of good quality. Sensitivity analyses including only these high
quality studies showed a somewhat lower, but still significant, effect size for body
weight. The overall effects on waist circumference and insulin were no longer
significant in the sensitivity analysis. Depressive symptoms were only reported in
four studies, which were of low quality. These results should thus be interpreted
cautiously. In particular, in three of the four studies, the control condition
consisted of a waiting list without active control treatment, indicating that non-
specific effects of the intervention (e.g. extra attention, peer support) were not
controlled for. Because these studies were of low quality and the effect size was on
the border of significance, we cannot state with absolute certainty that lifestyle
interventions effectively reduce depression.
Our findings are mostly consistent with the existing literature regarding the
effects of lifestyle interventions on cardiometabolic risk in the general population.
These studies found significant effects for waist circumference, fasting glucose,
triglycerides [65] and insulin concentrations [66], but not one of them found a
change in cholesterol levels [65–67]. In one study a significant effect for lifestyle
interventions on systolic blood pressure was reported [67]; a finding that could
not be replicated in our meta-analysis. In sum, lifestyle interventions seem to be
effective in reducing most metabolic risk factors; only cholesterol and blood
pressure seemed unaffected. However, the effects on waist circumference and
insulin were no longer significant in the sensitivity analysis in which only the high
quality studies were considered.
The characteristics of treatments were examined to provide guidelines for
future clinical practice. Studies characterized by an individual approach seemed
more effective than group-based interventions, while combining group treatment
with individual interventions appeared to get the best result on body weight.
Apparently the benefits of an individual approach, such as personal attention,
advice, a tailor-made action plan and meeting patient-specific needs, surpass the
benefits of group-sessions, such as group cohesiveness, interpersonal learning,
imitative behavior, recognition of similarities in other group members [68, 69]
and peer support [70]. That a combined approach is most effective could well be
explained by the fact that these interventions encompass ‘the best of both worlds’:
imitative behavior, peer support and recognition of similarities in others during
group-sessions and addressing personal needs during the individual meetings.
Unfortunately, we could not identify elements specific for successful
interventions. This is at odds with previous literature suggesting that diet, physical
activity and psychological interventions all had an individual contribution to
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losing weight [12–14]. A previous meta-analysis [15] performed subgroup
analyses to calculate effect sizes for diet, no diet, CBT, psycho-education, physical
activity and no physical activity among others. However, these pooled effect sizes
are difficult to interpret and may lead to unreliable conclusions since none of the
interventions consisted of just one of these elements. Thus, when examining for
example the effects of psychological interventions, effects of other interventions
such as diet-instructions could not be filtered out, making a direct comparison of
specific elements of interventions impossible.
Finally, we found that interventions based in Asia show larger effect sizes than
the studies based in Central or Northern Europe, even though there were no
differences between the continents with regard to the duration, intensity or
elements used in the interventions or weight of the patients at the start of the
intervention. This aspect has not been studies before. We find ourselves unable to
explain these differences with the data currently available. Future research might
elucidate these findings.
Limitations
There was significant heterogeneity among the studies, suggesting that there were
differences in the effectiveness of the lifestyle interventions that could not be a
result of chance alone. Therefore, Cohen’s d has to be interpreted with caution.
Based on the funnel plots and Egger’s test for asymmetry, we could not rule out
the possibility of publication bias with regard to long term effects on body weight
and the effects on diastolic blood pressure. This could indicate an overestimation
of the reported effect sizes for these outcomes. Furthermore, the effects for some
parameters of the metabolic syndrome and depression were based on a small
number of studies. The CTAM revealed that the quality of the included studies
was quite poor, with 21 out of 25 studies not meeting its standards. This questions
the reliability of the effect sizes, since low quality studies tend to overestimate
effects. Last, BMI change could be seen as a more meaningful outcome than
weight change as it takes the height of the patients into account. Alternatively, we
chose to report waist circumference and other metabolic parameters alongside
body weight. Waist circumference is one of the main risk factors for
cardiovascular morbidity [71–73]. Abdominal obesity stimulates insulin resis-
tance, which can result in elevated triglyceride concentrations, diabetes and
hypertension. All of these present an increased risk of developing cardiovascular
diseases [73, 74].
Clinical implications and future research
Lifestyle interventions in general lead to body weight loss and prevent weight gain.
However, as we found no evidence for the superiority of a specific intervention
model of component –other than using an individual approach- we cannot make
recommendations regarding the content of lifestyle interventions. To find out
which elements are more effective than others, we should test them all separately,
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which would be an expensive and time-consuming exercise. Also, an intervention
could be more than the sum of its separate elements. It might help if future studies
provided clear and detailed depictions of the content of their lifestyle
interventions.
Lifestyle interventions might improve other metabolic risk factors than body
weight alone, and might also improve depressive symptoms, even though only few
studies reported on these outcome measures. We urge researchers investigating
effects of lifestyle interventions in people with psychotic disorders to include these
measures to further substantiate these findings. Given their positive effects on
multiple outcomes, we recommend lifestyle interventions to be listed among other
evidence based psychosocial treatments for psychosis and to be included in
clinical guidelines.
The CTAM considered most of the included studies to be of poor quality. We
would like to underline the importance of high quality research in order to obtain
reliable results, as well as to urge researchers to properly describe the design and
execution of their studies.
Supporting Information
Figure S1. Forest plot a) describes the effects of weight loss interventions.
Forest plot b) describes the effects of weight gain prevention interventions.
doi:10.1371/journal.pone.0112276.s001 (TIF)
Figure S2. Forest plot a) describes the sensitivity analysis of the effects of
lifestyle interventions on body weight. Forest plot b) describes the sensitivity
analysis of the effects of lifestyle interventions on waist circumference. Forest plot
c) describes the sensitivity analysis of the effects of lifestyle interventions on
insulin.
doi:10.1371/journal.pone.0112276.s002 (TIF)
Figure S3. Forest plot a) describes the longterm follow-up effects of weight loss
interventions on bodyweight. Forest plot b) describes the longterm follow-up
effects of weight gain prevention interventions on bodyweight.
doi:10.1371/journal.pone.0112276.s003 (TIF)
Figure S4. Forest plot a) describes the effects of individual interventions. Forest
plot b) describes the effects of group interventions. Forest plot c) describes the
effects of combined interventions.
doi:10.1371/journal.pone.0112276.s004 (TIF)
Checklist S1. PRISMA checklist.
doi:10.1371/journal.pone.0112276.s005 (DOC)
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